MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3

被引:3
|
作者
Wang, Xianjue [1 ]
Wei, Ping [2 ]
Yang, Ling [1 ]
Liu, Fangyuan [1 ]
Tong, Xin [1 ]
Yang, Xiaoyu [1 ]
Su, Liya [1 ,3 ]
机构
[1] Inner Mongolia Med Univ, Affiliated Hosp, Inner Mongolia Key Lab Med Cell Biol, Clin Med Res Ctr, Hohhot 010050, Inner Mongolia, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Basic Med Coll, Dept Med Immunol, Tai An 271000, Shandong, Peoples R China
[3] Inner Mongolia Med Univ, Clin Med Res Ctr, Affiliated Hosp, 1 Tongdao North St, Hohhot 010050, Inner Mongolia, Peoples R China
关键词
Epithelial-mesenchymal transition; Hepatocellular carcinoma; miR-20a-5p; RUNX3; TUMOR-SUPPRESSOR GENE; EXPRESSION; CANCER; MIR-20A-5P; MIGRATION; PROMOTES; INVASION; CELLS; LIVER;
D O I
10.1097/CM9.0000000000001975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:MicroRNA-20a (miR-20a) is dysregulated in many types of malignancies, including human hepatocellular carcinoma (HCC), but its expression level and functional significance in HCC are still disputed. We aimed to study the role of miR-20a-5p in HCC and its downstream molecular mechanisms.Methods:We used real-time polymerase chain reaction to detect the expression of miR-20a-5p and runt-related transcription factor 3 (RUNX3) in HCC and paraneoplastic tissue, transfected Huh7 and highly metastatic human hepatocellular carcinoma (MHCC97H) cells. A live cell workstation was used to observe the proliferation and migration of transfected cells. The invasiveness of transfected cells was verified by Transwell assay. Cell apoptosis was detected by flow cytometry. The expression levels of proteins after transfection were measured using simple western immunoblot measurements. Gene expression profiles between HCC and normal samples were obtained from The Cancer Genome Atlas. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment results were processed by the database for annotation, visualization and integrated discovery. Potential target genes of miR-20a-5p were predicted to further investigate how miR-20a-5p regulates epithelial-mesenchymal transition (EMT) in HCC.Results:MiR-20a-5p was significantly highly expressed in HCC tissues, and overexpression of miR-20a-5p significantly promoted HCC cell proliferation, migration, and invasion and inhibited apoptosis in vitro. The protein expression of E-cadherin was decreased and that of vimentin was increased after overexpression of miR-20a-5p in HCC cells. We discovered the intersection of genes from miRDB, miR TarBase, and TargetScan, obtained 397 target genes and finally focused on RUNX3. RUNX3 was not only reduced in HCC specimens but also drastically reduced in HCC cells overexpressing miR-20a-5p. RUNX3 expression decreased with elevated miR-20a-5p, which activated downstream EMT signaling and promoted cell proliferation, migration, and invasion.Conclusions:Since RUNX3 is involved in EMT in HCC, as proven by previous research, our findings provide further evidence for a novel regulatory pathway comprising the miR-20a/RUNX3/EMT axis that upregulates EMT signaling and enhances the migration of HCC cells.
引用
收藏
页码:2089 / 2097
页数:9
相关论文
共 50 条
  • [31] Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma
    Choi, Hye-Sun
    Yim, Seon-Hee
    Xu, Hai-Dong
    Jung, Seung-Hyun
    Shin, Seung-Hun
    Hu, Hae-Jin
    Jung, Chan-Kwon
    Choi, Jong Young
    Chung, Yeun-Jun
    BMC CANCER, 2010, 10
  • [32] Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma
    Hye-Sun Choi
    Seon-Hee Yim
    Hai-Dong Xu
    Seung-Hyun Jung
    Seung-Hun Shin
    Hae-Jin Hu
    Chan-Kwon Jung
    Jong Young Choi
    Yeun-Jun Chung
    BMC Cancer, 10
  • [33] CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
    Yang, Gang
    Wang, Guan
    Xiong, Yongfu
    Sun, Ji
    Li, Weinan
    Tang, Tao
    Li, Jingdong
    MOLECULAR MEDICINE REPORTS, 2021, 24 (01)
  • [34] Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition
    Ke-Zhu Hou
    Zhi-Qiang Fu
    Hua Gong
    World Journal of Gastroenterology, 2015, (02) : 475 - 483
  • [35] Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition
    Hou, Ke-Zhu
    Fu, Zhi-Qiang
    Gong, Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (02) : 475 - 483
  • [36] miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3
    Gu, Hao
    Gu, Shensen
    Zhang, Xinlong
    Zhang, Songjiang
    Zhang, Dongming
    Lin, Junsheng
    Hasengbayi, Saiken
    Han, Wei
    CANCER MEDICINE, 2019, 8 (15): : 6756 - 6767
  • [37] Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'
    Cristobal, Ion
    Santos, Andrea
    Gonzalez, Silvia
    Luque, Melania
    Torrejon, Blanca
    Rojo, Federico
    Garcia-Foncillas, Jesus
    BRITISH JOURNAL OF CANCER, 2018, 118 (07) : 1028 - 1029
  • [38] Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5'UTR of RUNX3
    Zhang, Jiantao
    Zhou, Wenli
    Liu, Yanyan
    Liu, Tao
    Li, Chenyao
    Wang, Lei
    ONCOLOGY LETTERS, 2018, 15 (05) : 7215 - 7220
  • [39] miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4
    Dou, Changwei
    Liu, Zhikui
    Xu, Meng
    Jia, Yuli
    Wang, Yufeng
    Li, Qing
    Yang, Wei
    Zheng, Xin
    Tu, Kangsheng
    Liu, Qingguang
    CANCER LETTERS, 2016, 381 (02) : 380 - 390
  • [40] miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
    Chen, Jing-song
    Liang, Li-li
    Xu, Hong-xu
    Chen, Fan
    Shen, Shun-li
    Chen, Wei
    Chen, Lian-Zhou
    Su, Qiao
    Zhang, Long-juan
    Bi, Jiong
    Zeng, Wen-Tao
    Li, Wen
    Ma, Ning
    Huang, Xiao-Hui
    ONCOTARGET, 2017, 8 (42) : 71418 - 71429